Discontinuation of antipsychotic medication-time to rethink trial design

Helene Speyer*, Marieke Begemann, Nikolai Albert, Amber Weller, Merete Nordentoft, Wim Veling, Iris E Sommer, Kelly Allott, Eóin Killackey

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)841-842
Number of pages2
JournalThe Lancet. Psychiatry
Volume7
Issue number10
DOIs
Publication statusPublished - Oct-2020

Keywords

  • Antipsychotic Agents/therapeutic use
  • Humans
  • Medication Adherence
  • Patient Dropouts
  • Patient Selection
  • Psychotic Disorders/drug therapy
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Research Design

Cite this